Protein based tumor necrosis factor-receptor variants for the treatment of TNF related disorders
US7144987B1 · kind B1 · utility
11Cited by
15References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 3, 2003 |
| Grant date | Dec 5, 2006 |
| Priority date | — |
| Expiry date | Aug 20, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/525
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel proteins with TNF-receptor antagonist activity and nucleic acids encoding these proteins. The invention further relates to TNF-receptor proteins with reduced immunogenicity and the use of these novel proteins in the treatment of TNF related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.